BCA2/Rabring7 Targets HIV-1 Gag for Lysosomal Degradation in a Tetherin-Independent Manner

PLoS Pathogens

Volumn 10, Issue 5, 2014, Pages

  Nityanandam, Ramya ^a   Serra Moreno, Ruth ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCA2; GAG PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; BST2 PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LEUKOCYTE ANTIGEN; PROTEIN BINDING; RNF115 PROTEIN, HUMAN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LYSATE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYMATIC DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; INFLUENZA; PROTEIN DEGRADATION; UBIQUITINATION; VIRUS RELEASE; VIRUS REPLICATION; WESTERN BLOTTING; CELL CULTURE; CHEMISTRY; HEK293 CELL LINE; JURKAT CELL LINE; LYSOSOME; METABOLISM; PHYSIOLOGY; PROTEIN DOMAIN; SIMIAN IMMUNODEFICIENCY VIRUS;

ANTIGENS, CD; ANTIVIRAL AGENTS; CELLS, CULTURED; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENE PRODUCTS, GAG; GPI-LINKED PROTEINS; HEK293 CELLS; HIV-1; HUMANS; JURKAT CELLS; LYSOSOMES; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEOLYSIS; SIMIAN IMMUNODEFICIENCY VIRUS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84901649911     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004151     Document Type: Article

References (47)

1. Bushman FD, Malani N, Fernandes J, D'Orso I, Cagney G, et al. (2009) Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog 5: e1000437.
2. Kirchhoff F, (2010) Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8: 55-67.
3. Wolf D, Goff SP, (2008) Host restriction factors blocking retroviral replication. Annu Rev Genet 42: 143-163.
4. Evans DT, Serra-Moreno R, Singh RK, Guatelli JC, (2010) BST-2/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol 18: 388-396.
5. Sheehy AM, Gaddis NC, Choi JD, Malim MH, (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418: 646-650.
6. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, et al. (2004) TRIM5α restricts HIV-1 infection in Old World monkeys. Nature 427: 848-853.
7. Hatziioannou T, Perez-Caballero D, Yang A, Cowan S, Bieniasz PD, (2004) Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc Natl Acad Sci U S A 101: 10774-10779.
8. Stremlau M, Perron M, Welikala S, Sodroski J, (2005) Species-specific variation in the B30.2(SPRY) domain of TRIM5a determines the potency of human immunodeficiency virus restriction. J Virol 79: 3139-3145.
9. Song B, Javanbakht H, Perron M, Park DH, Stremlau M, et al. (2005) Retrovirus restriction by TRIM5a variants from Old World and New World primates. J Virol 79: 3930-3937.
10. Yap MW, Nicole S, Stoye JP, (2005) A single amino acid in the SPRY domain of human TRIM5alpha leads to HIV-1 restriction. Curr Biol 15: 73-78.
11. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, et al. (2011) SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474: 654-657.
12. Laguette N, Rahm N, Sobhian B, Chable-Bessia C, Munch J, et al. (2012) Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein. Cell Host Microbe 11: 205-217.
13. Harris RS, Petersen-Mahrt SK, Neuberger MS, (2002) RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol Cell 10: 1247-1253.
14. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, et al. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell 113: 803-809.
15. Neil SJ, Zang T, Bieniasz PD, (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451: 425-430.
16. Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, et al. (2008) The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3: 245-252.
17. Goujon C, Moncorge O, Bauby H, Doyle T, Ward CC, et al. (2013) Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 502: 559-562.
18. Liu Z, Pan Q, Ding S, Qian J, Xu F, et al. (2013) The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe 14: 398-410.
19. Kane M, Yadav SS, Bitzegeio J, Kutluay SB, Zang T, et al. (2013) MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 502: 563-566.
20. Jouvenet N, Neil SJ, Zhadina M, Zang T, Kratovac Z, et al. (2009) Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J Virol 83: 1837-1844.
21. Le Tortorec A, Neil SJ, (2009) Antagonism and intracellular sequestration of human tetherin by the HIV-2 envelope glycoprotein. J Virol 83: 11966-11978.
22. Jia B, Serra-Moreno R, Neidermyer W, Rahmberg A, Mackey J, et al. (2009) Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog 5: e1000429.
23. Zhang F, Wilson SJ, Landford WC, Virgen B, Gregory D, et al. (2009) Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 6: 54-67.
24. Sauter D, Schindler M, Specht A, Landford WN, Munch J, et al. (2009) Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 6: 409-421.
25. Serra-Moreno R, Zimmermann K, Stern LJ, Evans DT, (2013) Tetherin/BST-2 Antagonism by Nef Depends on a Direct Physical Interaction between Nef and Tetherin, and on Clathrin-mediated Endocytosis. PLoS Pathog 9: e1003487.
26. Zhang F, Landford WN, Ng M, McNatt MW, Bieniasz PD, et al. (2011) SIV Nef proteins recruit the AP-2 complex to antagonize Tetherin and facilitate virion release. PLoS Pathog 7: e1002039.
27. Miyakawa K, Ryo A, Murakami T, Ohba K, Yamaoka S, et al. (2009) BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction. PLoS Pathog 5: e1000700.
28. Mizuno K, Kitamura A, Sasaki T, (2003) Rabring7, a novel Rab7 target protein with a RING finger motif. Mol Biol Cell 14: 3741-3752.
29. Serra-Moreno R, Jia B, Breed M, Alvarez X, Evans DT, (2011) Compensatory Changes in the Cytoplasmic Tail of gp41 Confer Resistance to Tetherin/BST-2 in a Pathogenic Nef-Deleted SIV. Cell Host Microbe 9: 46-57.
30. Goffinet C, Schmidt S, Kern C, Oberbremer L, Keppler OT, (2010) Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses. J Virol 84: 11374-11384.
31. Amemiya Y, Azmi P, Seth A, (2008) Autoubiquitination of BCA2 RING E3 ligase regulates its own stability and affects cell migration. Mol Cancer Res: MCR 6: 1385-1396.
32. Burger AM, Gao Y, Amemiya Y, Kahn HJ, Kitching R, et al. (2005) A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer. Cancer Res 65: 10401-10412.
33. Bacopulos S, Amemiya Y, Yang W, Zubovits J, Burger A, et al. (2012) Effects of partner proteins on BCA2 RING ligase activity. BMC Cancer 12: 63.
34. Brahemi G, Kona FR, Fiasella A, Buac D, Soukupova J, et al. (2010) Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer. J Med Chem 53: 2757-2765.
35. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, et al. (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science 319: 921-926.
36. Naarding MA, Baan E, Pollakis G, Paxton WA, (2007) Effect of chloroquine on reducing HIV-1 replication in vitro and the DC-SIGN mediated transfer of virus to CD4+ T-lymphocytes. Retrovirology 4: 6.
37. Savarino A, Gennero L, Sperber K, Boelaert JR, (2001) The anti-HIV-1 activity of chloroquine. J Clin Virol 20: 131-135.
38. Savarino A, Gennero L, Chen HC, Serrano D, Malavasi F, et al. (2001) Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity. AIDS 15: 2221-2229.
39. Chiang G, Sassaroli M, Louie M, Chen H, Stecher VJ, et al. (1996) Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine. Clin Ther 18: 1080-1092.
40. Alexander L, Du Z, Rosenzweig M, Jung JU, Desrosiers RC, (1997) A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation. J Virol 71: 6094-6099.
41. Hatziioannou T, Perez-Caballero D, Yang A, Cowan S, Bieniasz PD, (2004) Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5α. Proc Natl Acad Sci U S A 101: 10774-10779.
42. Sakane A, Hatakeyama S, Sasaki T, (2007) Involvement of Rabring7 in EGF receptor degradation as an E3 ligase. Biochem Biophys Res Comm 357: 1058-1064.
43. Smith CJ, Berry DM, McGlade CJ, (2013) The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal sorting of the epidermal growth factor receptor. J Cell Sci 126: 1366-1380.
44. Smirnova EV, Collingwood TS, Bisbal C, Tsygankova OM, Bogush M, et al. (2008) TULA proteins bind to ABCE-1, a host factor of HIV-1 assembly, and inhibit HIV-1 biogenesis in a UBA-dependent fashion. Virology 372: 10-23.
45. Hermida-Matsumoto L, Resh MD, (2000) Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging. J Virol 74: 8670-8679.
46. Kestler HW, Ringler DJ, Mori K, Panicali DL, Sehgal PK, et al. (1991) Importance of the nef gene for maintenance of high virus loads and for the development of AIDS. Cell 65: 651-662.
47. Regier DA, Desrosiers RC, (1990) The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res Hum Retro 6: 1221-1231.